Cerebrovascular dysfunction, including reduced cerebral blood flow (CBF) and cerebrovascular reactivity (CVR), contributes to Alzheimer’s disease (AD). Caloric restriction (CR) and resveratrol (Rsv) benefit vascular health, yet their impact on CBF and CVR in AD remains unclear. Here, we investigated the cerebrovascular effects of 40% CR or Rsv supplementation in WT and TgF344-AD rats. Using pseudo-continuous arterial spin labelling (pCASL) MRI, we observed that male Tg control (Ctrl) rats exhibited reduced relative CBF (rCBF) and absolute CBF (aCBF) in the caudate-putamen at baseline compared to WT Ctrl and Tg Rsv rats, while Rsv restored CBF to WT levels. Male Rsv rats also showed higher rCBF than CR rats in the somatosensory cortex, irrespective of genotype. In the cingulate cortex, male Tg rats had lower rCBF than WT, irrespective of treatment. During hypercapnia, Tg males displayed lower rCBF and aCBF across multiple regions, while Rsv increased rCBF in cingulate cortex and somatosensory cortex, regardless of genotype. In females, treatments did not affect baseline or hypercapnic CBF, although CR and Rsv reduced CVR compared to Ctrl. In summary, these findings suggest Rsv reverses AD-related hypoperfusion in males, whereas CR may impair cerebrovascular responsiveness in females, highlighting the need for sex-specific therapeutic strategies.
DeTureMADicksonDW.The neuropathological diagnosis of Alzheimer’s disease. Mol Neurodegener2019; 14: 32.
2.
HardyJAHigginsGA.Alzheimer’s disease: the amyloid cascade hypothesis. Science1992; 256: 184–185.
3.
DaiWYLopezOLCarmichaelOT, et al. Mild cognitive impairment and Alzheimer disease: patterns of altered cerebral blood flow at MR imaging. Radiology2009; 250: 856–866.
4.
MattssonNTosunDInselPS, et al. Association of brain amyloid-beta with cerebral perfusion and structure in Alzheimer’s disease and mild cognitive impairment. Brain2014; 137: 1550–1561.
5.
WeijsRWJShkredovaDABrekelmansACM, et al. Longitudinal changes in cerebral blood flow and their relation with cognitive decline in patients with dementia: current knowledge and future directions. Alzheimers Dement2023; 19: 532–548.
6.
WeijsRWJOudegeest-SanderMHHopmanMTE, et al. Cerebrovascular CO2 reactivity and dynamic cerebral autoregulation through the eighth decade of life and their implications for cognitive decline. J Cereb Blood Flow Metab2024; 44: 712–725.
7.
AslanyanVMackWJOrtegaNE, et al. Cerebrovascular reactivity in Alzheimer’s disease signature regions is associated with mild cognitive impairment in adults with hypertension. Alzheimers Dement2024; 20: 1784–1796.
8.
SurSLinZLiY, et al. Association of cerebrovascular reactivity and Alzheimer pathologic markers with cognitive performance. Neurology2020; 95: e962–e972.
9.
BeaudinAEMcCrearyCRMazerolleEL, et al. Cerebrovascular reactivity across the entire brain in cerebral amyloid angiopathy. Neurology2022; 98: e1716–e1728.
10.
WangCXYReidGMackayCE, et al. A systematic review of the association between dementia risk factors and cerebrovascular reactivity. Neurosci Biobehav Rev2023; 148: 105140.
11.
JackCRJrBennettDABlennowK, et al. NIA-AA Research Framework: toward a biological definition of Alzheimer’s disease. Alzheimers Dement2018; 14: 535–562.
12.
ParikhIGuoJChuangKH, et al. Caloric restriction preserves memory and reduces anxiety of aging mice with early enhancement of neurovascular functions. Aging2016; 8: 2814–2826.
13.
KimHKangHHeoRW, et al. Caloric restriction improves diabetes-induced cognitive deficits by attenuating neurogranin-associated calcium signaling in high-fat diet-fed mice. J Cereb Blood Flow Metab2016; 36: 1098–1110.
14.
García-PrietoCFFernández-AlfonsoMS.Caloric restriction as a strategy to improve vascular dysfunction in metabolic disorders. Nutrients2016; 8: 370.
15.
KennedyDOWightmanELReayJL, et al. Effects of resveratrol on cerebral blood flow variables and cognitive performance in humans: a double-blind, placebo-controlled, crossover investigation. Am J Clin Nutr2010; 91: 1590–1597.
16.
ZhuPJinYSunJ, et al. The efficacy of resveratrol supplementation on inflammation and oxidative stress in type-2 diabetes mellitus patients: randomized double-blind placebo meta-analysis. Front Endocrinol2024; 15: 1463027.
17.
QuartaAGaballoAPradhanB, et al. Beneficial oxidative stress-related trans-resveratrol effects in the treatment and prevention of breast cancer. Appl Sci2021; 11: 11041.
18.
Navarro-CruzARJuarez-SerranoDCesar-ArteagaI, et al. Oral administration of resveratrol reduces oxidative stress generated in the hippocampus of Wistar rats in response to consumption of ethanol. Front Behav Neurosci2023; 17: 1304006.
19.
ParsamaneshNAsghariASardariS, et al. Resveratrol and endothelial function: a literature review. Pharmacol Res2021; 170: 105725.
20.
van RooijJRAvan den BergMVasilkovskaT, et al. Short-term caloric restriction or resveratrol supplementation alters large-scale brain network connectivity in male and female rats. Front Nutr2025; 12: 1440373.
21.
van RooijJRAvan den BergMVan VosselenM, et al. Long-term dietary interventions fail to mitigate functional connectivity loss and cognitive decline in the TgF344-AD rat model of Alzheimer’s disease. Exp Neurol2026; 398: 115647.
22.
Lopez-LeeCTorresERSCarlingG, et al. Mechanisms of sex differences in Alzheimer’s disease. Neuron2024; 112: 1208–1221.
23.
MoutinhoS.Women twice as likely to develop Alzheimer’s disease as men – but scientists do not know why. Nat Med2025; 31: 704–707.
24.
ZhuDMontagneAZhaoZ.Alzheimer’s pathogenic mechanisms and underlying sex difference. Cell Mol Life Sci2021; 78: 4907–4920.
25.
Abi-GhanemCRobisonLSZuloagaKL.Androgens’ effects on cerebrovascular function in health and disease. Biol Sex Differ2020; 11: 35.
26.
KrauseDNDucklesSPPelligrinoDA.Influence of sex steroid hormones on cerebrovascular function. J Appl Physiol2006; 101: 1252–1261.
27.
GhisleniCBollmannSBiason-LauberA, et al. Effects of steroid hormones on sex differences in cerebral perfusion. PLoS One2015; 10: e0135827.
28.
DinhDDWanHLidingtonD, et al. Female mice display sex-specific differences in cerebrovascular function and subarachnoid haemorrhage-induced injury. EBioMedicine2024; 102: 105058.
29.
AncesBMGreenbergJHDetreJA.Sex differences in the cerebral blood flow response after brief hypercapnia in the rat. Neurosci Lett2001; 304: 57–60.
30.
Al AttarAAFahedGIHoballahMM, et al. Mechanisms underlying the effects of caloric restriction on hypertension. Biochem Pharmacol2022; 200: 115035.
31.
DzatorJSACouplandKGHowePRC.Exploring the effects of resveratrol supplementation on cerebrovascular function in hormonal migraineurs: a pilot study. IBRO Neurosci Rep2023; 15: 310–319.
32.
DaiWGarciaDde BazelaireC, et al. Continuous flow-driven inversion for arterial spin labeling using pulsed radio frequency and gradient fields. Magn Reson Med2008; 60: 1488–1497.
33.
MonteiroSPHirschlerLBarbierEL, et al. High-resolution perfusion imaging in rodents using pCASL at 9.4 T. NMR Biomed2025; 38: e5288.
34.
TaghvaeiMDoluiSSadaghianiS, et al. Regional cerebral blood flow reflects both neurodegeneration and microvascular integrity across the Alzheimer’s continuum. Alzheimers Dement2025; 21: e14382.
35.
ZhangHWangYLyuD, et al. Cerebral blood flow in mild cognitive impairment and Alzheimer’s disease: a systematic review and meta-analysis. Ageing Res Rev2021; 71: 101450.
36.
YanLRLiuCYWongKP, et al. Regional association of pCASL–MRI with FDG–PET and PiB–PET in people at risk for autosomal dominant Alzheimer’s disease. Neuroimage Clin2018; 17: 751–760.
37.
ThroppPPhillipsEJungY, et al. Arterial spin labeling perfusion MRI in the Alzheimer’s Disease Neuroimaging Initiative: past, present, and future. Alzheimers Dement2024; 20: 8937–8952.
38.
Cruz HernandezJCBrackoOKersbergenCJ, et al. Neutrophil adhesion in brain capillaries reduces cortical blood flow and impairs memory function in Alzheimer’s disease mouse models. Nat Neurosci2019; 22: 413–420.
39.
ShenZLeiJLiX, et al. Multifaceted assessment of the APP/PS1 mouse model for Alzheimer’s disease: applying MRS, DTI, and ASL. Brain Res2018; 1698: 114–120.
40.
HebertFGrand’maisonMHoMK, et al. Cortical atrophy and hypoperfusion in a transgenic mouse model of Alzheimer’s disease. Neurobiol Aging2013; 34: 1644–1652.
41.
GuoYLiXZhangM, et al. Age- and brain region-associated alterations of cerebral blood flow in early Alzheimer’s disease assessed in AbetaPPSWE/PS1DeltaE9 transgenic mice using arterial spin labeling. Mol Med Rep2019; 19: 3045–3052.
42.
van der ThielMRodriguezCVan De VilleD, et al. Regional cerebral perfusion and cerebrovascular reactivity in elderly controls with subtle cognitive deficits. Front Aging Neurosci2019; 11: 19.
43.
YezhuvathUSUhJChengY, et al. Forebrain-dominant deficit in cerebrovascular reactivity in Alzheimer’s disease. Neurobiol Aging2012; 33: 75–82.
44.
MuntingLPDerieppeMSuidgeestE, et al. Cerebral blood flow and cerebrovascular reactivity are preserved in a mouse model of cerebral microvascular amyloidosis. Elife2021; 10: e61279.
45.
VasilkovskaTSalajegheSVanreuselV, et al. Longitudinal alterations in brain perfusion and vascular reactivity in the zQ175DN mouse model of Huntington’s disease. J Biomed Sci2024; 31: 37.
46.
ChenJJ.Cerebrovascular-reactivity mapping using MRI: considerations for Alzheimer’s disease. Front Aging Neurosci2018; 10: 170.
47.
Percie du SertNAhluwaliaAAlamS, et al. Reporting animal research: explanation and elaboration for the ARRIVE guidelines 2.0. PLoS Biol2020; 18: e3000411.
48.
HirschlerLDebackerCSVoironJ, et al. Interpulse phase corrections for unbalanced pseudo-continuous arterial spin labeling at high magnetic field. Magn Reson Med2018; 79: 1314–1324.
49.
ShenQHuangSDuongTQ.Ultra-high spatial resolution basal and evoked cerebral blood flow MRI of the rat brain. Brain Res2015; 1599: 126–136.
50.
PaxinosGWatsonC.The rat brain in stereotaxic coordinates. 6th ed.San Diego, CA: Academic Press, 2007.
51.
OzturkBOMonteBKoundalS, et al. Disparate volumetric fluid shifts across cerebral tissue compartments with two different anesthetics. Fluids Barriers CNS2021; 18: 1.
52.
BuxtonRBFrankLRWongEC, et al. A general kinetic model for quantitative perfusion imaging with arterial spin labeling. Magn Reson Med1998; 40: 383–396.
53.
MillerVM.Sex-based differences in vascular function. Womens Health2010; 6: 737–752.
54.
JiaKLuoXYiJ, et al. Hormonal influence: unraveling the impact of sex hormones on vascular smooth muscle cells. Biol Res2024; 57: 61.
55.
RobertJ.Sex differences in vascular endothelial cells. Atherosclerosis2023; 384: 117278.
56.
KawanoHYamadaSWatanabeY, et al. Aging and sex differences in brain volume and cerebral blood flow. Aging Dis2024; 15: 2216–2229.
SussmanBLWisemanHERanganathanS, et al. Sex differences in the neurovascular health of aging adults. Stroke2025; 56: 2177–2189.
59.
TallonCMBarkerARNowak-FluckD, et al. The influence of age and sex on cerebrovascular reactivity and ventilatory response to hypercapnia in children and adults. Exp Physiol2020; 105: 1090–1101.
60.
BetaiDAhmedASSaxenaP, et al. Gender disparities in cardiovascular disease and their management: a review. Cureus2024; 16: e59663.
61.
RajendranAMinhasASKazziB, et al. Sex-specific differences in cardiovascular risk factors and implications for cardiovascular disease prevention in women. Atherosclerosis2023; 384: 117269.
62.
MielkeMMVemuriPRoccaWA.Clinical epidemiology of Alzheimer’s disease: assessing sex and gender differences. Clin Epidemiol2014; 6: 37–48.
63.
DeCasienARGumaELiuS, et al. Sex differences in the human brain: a roadmap for more careful analysis and interpretation of a biological reality. Biol Sex Differ2022; 13: 43.
64.
Abu RayaMZeltzerEBlazhenetsG, et al. Sex differences in amyloid PET in a large, real-world sample from the Imaging Dementia-Evidence for Amyloid Scanning (IDEAS) study. Alzheimers Dement2025; 21: e70304.
65.
OveisgharanSArvanitakisZYuL, et al. Sex differences in Alzheimer’s disease and common neuropathologies of aging. Acta Neuropathol2018; 136: 887–900.
66.
HuYTChenXLZhangYN, et al. Sex differences in hippocampal beta-amyloid accumulation in the triple-transgenic mouse model of Alzheimer’s disease and the potential role of local estrogens. Front Neurosci2023; 17: 1117584.
67.
YangJTWangZJCaiHY, et al. Sex differences in neuropathology and cognitive behavior in APP/PS1/tau triple-transgenic mouse model of Alzheimer’s disease. Neurosci Bull2018; 34: 736–746.
68.
SilAErfaniALambN, et al. Sex differences in behavior and molecular pathology in the 5XFAD model. J Alzheimers Dis2022; 85: 755–778.
69.
ChaudryONdukweKXieL, et al. Females exhibit higher GluA2 levels and outperform males in active place avoidance despite increased amyloid plaques in TgF344-Alzheimer’s rats. Sci Rep2022; 12: 19129.
70.
BrackoOHernándezJCCParkL, et al. Causes and consequences of baseline cerebral blood flow reductions in Alzheimer’s disease. J Cereb Blood Flow Metab2021; 41: 1501–1516.
71.
NiuXXGuoYChangZY, et al. The correlation between changes in gray matter microstructure and cerebral blood flow in Alzheimer’s disease. Front Aging Neurosci2023; 15: 1205838.
72.
CaffarraPGhettiCConcariL, et al. Differential patterns of hypoperfusion in subtypes of mild cognitive impairment. Open Neuroimag J2008; 2: 20–28.
73.
FangXBorderJJRiversPL, et al. Amyloid beta accumulation in TgF344-AD rats is associated with reduced cerebral capillary endothelial Kir2.1 expression and neurovascular uncoupling. Geroscience2023; 45: 2909–2926.
74.
JooILLaiAYBazzigaluppiP, et al. Early neurovascular dysfunction in a transgenic rat model of Alzheimer’s disease. Sci Rep2017; 7: 46427.
75.
WightmanELHaskell-RamsayCFReayJL, et al. The effects of chronic resveratrol supplementation on aspects of cognitive function, mood, sleep, health and cerebral blood flow in healthy, young humans. Br J Nutr2015; 114: 1427–1437.
76.
GarriguePMounienLChampionS, et al. Long-term administration of resveratrol at low doses improves neurocognitive performance as well as cerebral blood flow and modulates the inflammatory pathways in the brain. J Nutr Biochem2021; 97: 108786.
77.
DingBLingHWZhangY, et al. Pattern of cerebral hyperperfusion in Alzheimer’s disease and amnestic mild cognitive impairment using voxel-based analysis of 3D arterial spin-labeling imaging: initial experience. Clin Interv Aging2014; 9: 493–500.
78.
WangCXJiDLSuX, et al. Cerebral perfusion correlates with amyloid deposition in patients with mild cognitive impairment due to Alzheimer’s disease. J Prev Alzheimers Dis2025; 12: 100031.
79.
ZanettiMGortan CappellariGBurekovicI, et al. Caloric restriction improves endothelial dysfunction during vascular aging: effects on nitric oxide synthase isoforms and oxidative stress in rat aorta. Exp Gerontol2010; 45: 848–855.
80.
TropeaTMandalaM.Caloric restriction enhances vascular tone of cerebral and mesenteric resistance arteries in aged rats. Mech Ageing Dev2021; 197: 111520.
81.
RymanSGShaffNDoddA, et al. Reduced and delayed cerebrovascular reactivity in patients with Parkinson’s disease. Mov Disord2023; 38: 1262–1272.
82.
ChanSTMercaldoNDKwongKK, et al. Impaired cerebrovascular reactivity in Huntington’s disease. Front Physiol2021; 12: 663898.
83.
MarshallOChawlaSLuH, et al. Cerebral blood flow modulation insufficiency in brain networks in multiple sclerosis: a hypercapnia MRI study. J Cereb Blood Flow Metab2016; 36: 2087–2095.
84.
OgohS.Interaction between the respiratory system and cerebral blood flow regulation. J Appl Physiol2019; 127: 1197–1205.
85.
BergstromK.Cardiovascular and pulmonary effects of a new sedative analgesic (medetomidine) as a preanaesthetic drug in the dog. Acta Vet Scand1988; 29: 109–116.
86.
HawkleyTFPatelPMaaniCV.Isoflurane. StatPearls. Treasure Island, FL: StatPearls, 2025.
87.
GrandjeanJSchroeterABatataI, et al. Optimization of anesthesia protocol for resting-state fMRI in mice based on differential effects of anesthetics on functional connectivity patterns. Neuroimage2014; 102: 838–847.
88.
ZhangZRileyEChenS, et al. Age and gender-related patterns of arterial transit time and cerebral blood flow in healthy adults. Neuroimage2025; 309: 121098.
89.
YoshiuraTHiwatashiAYamashitaK, et al. Simultaneous measurement of arterial transit time, arterial blood volume, and cerebral blood flow using arterial spin-labeling in patients with Alzheimer disease. AJNR Am J Neuroradiol2009; 30: 1388–1393.
90.
HirschlerLMuntingLPKhmelinskiiA, et al. Transit time mapping in the mouse brain using time-encoded pCASL. NMR Biomed2018; 31: 3855.
